<DOC>
	<DOCNO>NCT00144833</DOCNO>
	<brief_summary>For HIV-infected individual highly resistant virus , high drug level may require block virus . This study investigate concept compare efficacy standard fosamprenavir/ritonavir increase dose boost fosamprenavir combination fosamprenavir ( increase dose ) /lopinavir/ritonavir .</brief_summary>
	<brief_title>Open Label Study 908/RTV Combination With Other PIs Treatment Multi PI-Experienced HIV Subjects</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>HIV Protease Inhibitors</mesh_term>
	<mesh_term>Fosamprenavir</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<criteria>Inclusion criterion : Multiple proteaseinhibitors experience HIV1 infected individual experience virological failure 's virus fully resistant boost fosamprenavir boost lopinavir base genotypic resistance test . Exclusion criterion : No full resistance FPV/r LPV/r Planned use NNRTIs part study salvage regimen Application additional exclusion criterion determine physician .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Protease inhibitors-experienced HIV-1 infect patient</keyword>
	<keyword>Highly-resistant HIV-1</keyword>
	<keyword>Dual boost Pis</keyword>
	<keyword>fosamprenavir</keyword>
	<keyword>lopinavir</keyword>
</DOC>